Does Rasburicase Interact with Lidocaine And Tetracaine?
CDI records a moderate classification for Rasburicase and Lidocaine And Tetracaine. The stored summary is: Antineoplastic agent that increases risk of methemoglobinemia when used concomitantly with lidocaine and tetracaine. The mechanism involves increased risk of methemoglobinemia. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Lidocaine And Tetracaine Class
- Amide Local Anesthetic
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
increased risk of methemoglobinemia
What To Tell Your Doctor or Pharmacist
If you are taking Rasburicase and your doctor is considering prescribing Lidocaine And Tetracaine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider